Apis Capital Advisors’s BioXcel Therapeutics BTAI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,500	Closed	-$836K	–	30
2022 Q1	$836K	Buy	+2,500	New	+$836K	1.01%	23
2021 Q2	–	Sell	-2,250	Closed	-$1.55M	–	40
2021 Q1	$1.55M	Buy	2,250 +1,000	+80%	+$691K	1.41%	22
2020 Q4	$924K	Buy	+1,250	New	+$924K	0.89%	27